Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 202Central Nervous System Neoplasms 122Brain Neoplasms 107Gliosarcoma 85Glioma 68Astrocytoma 63Oligodendroglioma 34Neuroblastoma 29Medulloblastoma 20Neoplasm Metastasis 19Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 14Ependymoma 11Diffuse Intrinsic Pontine Glioma 11Breast Neoplasms 11Meningeal Carcinomatosis 8Neoplasms 7Lymphoma 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6Optic Nerve Glioma 6Neuroectodermal Tumors, Primitive 6Lymphoma, Follicular 6Head and Neck Neoplasms 6Esthesioneuroblastoma, Olfactory 6Burkitt Lymphoma 6Spinal Cord Neoplasms 5Salivary Gland Neoplasms 5Rhabdoid Tumor 5Recurrence 5

Interventions

XENP 1595 2Cancer Vaccines 2Bevacizumab 2Adjuvants, Immunologic 2veliparib 1glutathione pegylated liposomal doxorubicin 1etoposide phosphate 1elacestrant 1binimetinib 1abemaciclib 1Trastuzumab 1Tissue Banks 1Temozolomide 1Radiotherapy 1Radiosurgery 1Radiation 1RAD1901 1Patient Discharge 1PF-07284890 1Midazolam 1Etoposide 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Diseases × Radiotherapy × CNS × Clear all
NCT00895960 2018-11-08

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Terminated
16 enrolled
CNSSarcoma

Brain Diseases, Central Nervous System Diseases, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡